Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 289 (RNA5SP289) is a processed pseudogene derived from a retrotransposed copy of the 5S ribosomal RNA gene. Unlike functional 5S rRNA—which is an approximately 120 nucleotide RNA molecule and a vital structural component of the large ribosomal subunit in all domains of life[1][3]—processed pseudogenes like RNA5SP289 are typically non-functional. They lack the introns and regulatory elements of their parental gene, often contain disabling mutations, and are not actively transcribed into functional RNA molecules[2][4]. Pseudogenes can occasionally play regulatory roles by acting as competitive endogenous RNAs or through other RNA-mediated mechanisms, but there is no direct evidential support that RNA5SP289 itself plays such a role. No drugs target this pseudogene, and it does not serve as a therapeutic or diagnostic target. Such pseudogenes are abundant in the genome and sometimes used to investigate the evolutionary history of gene families, but they are generally regarded as biologically inactive relics[2][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 289 (RNA5SP289).